Biosurgery Market by Product Type (Anti-adhesive & Hemostatic agents, Natural surgical & Synthetic surgical sealant, Cell-based matrices, Bone morphogenetic proteins, Demineralized bone matrix, Soft tissue management (Biologic mesh/patch, Allografts, Xenografts, Synthetic mesh/patch)) and Application (Cardiovascular, Neuro- and spine, Orthopedic, Reconstructive, Urology, and Gynecology Surgeries) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022
Biosurgery products are used in various surgeries to minimize the intra and post-operative complications. Various synthetic and biologic products like anti-adhesive agents, hemostatic agents, surgical sealing agents, bone graft substitutes, and soft tissue management are utilized in surgeries for preventing excessive blood loss or providing adhesion or wound/tissue sealing, and repair of damaged or weakened tissues or bones of a body. These advanced products enhance the work efficiency of physicians by controlling surgery-related difficulties in expensive and complicated surgeries.
The size of global biosurgery market is expected to increase substantially in the near future, owing to high investment, increasing R&D spending, aggressive strategies adopted by top players such as new product launches. Other factors that drive the growth of the biosurgery market are technological advancements (high efficiency products, multi-usage products and plasma based products), availability of multifunctional products, rising number of surgeries owing to the increasing rate of obesity and other lifestyle-related diseases, and increasing sports-related injuries. However, the high cost associated with surgeries, stern regulatory environment for product approval and growing popularity of minimally invasive surgeries are likely to restrict its growth in various regions.
The world biosurgery market was evaluated at $6,912.2 million in 2014, and is estimated to garner $12,758.1 million by 2022, registering a CAGR of 8.1% over the forecast period. The report segments the biosurgery market on the basis of product type, application, source, and geography. On the basis of product type, the market is segmented into anti-adhesive agents, hemostatic agents, surgical sealants, bone graft substitutes, and soft tissue management (mesh/patch). According to application, it is classified into cardiovascular and thoracic, neuro and spine, orthopedic, general, and others surgeries. Others surgery covers urological, gynecological, rhytidectomy, and reconstructive surgeries. Based on the source, it is segmented into natural and synthetic products. Geographic breakdown and a deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and LAMEA.
High investment from top players and increasing R&D spending on multi-usage products (such as fibrin sealants) are likely to provide ample opportunities to the industry players across regions. Recently in 2015, the U.S. FDA approved Infuse bone graft implantation from Medtronic PLC, which is made up of polyetheretherketone compound, for oblique lateral interbody fusion and anterior lumbar interbody fusion. Furthermore, in March 2015, Kuros Biosurgery received a U.S. patent for its synthetic hydrogel technology. It is a combination of bioactivebiomaterial products such as sealant and orthobiologics. A comprehensive competitive analysis and profiles of major industry players such as Johnson & Johnson (Ethicon), Baxter International, Medtronic PLC, Stryker, Atrium Medical (Maquet Getinge Group), C. R. Bard, CryoLife Inc., Haemostasis LLC, Kuros Bioscience, and Sanofi are also provided in this report.
KEY BENEFITS FOR STAKEHOLDERS:
The size of global biosurgery market is expected to increase substantially in the near future, owing to high investment, increasing R&D spending, aggressive strategies adopted by top players such as new product launches. Other factors that drive the growth of the biosurgery market are technological advancements (high efficiency products, multi-usage products and plasma based products), availability of multifunctional products, rising number of surgeries owing to the increasing rate of obesity and other lifestyle-related diseases, and increasing sports-related injuries. However, the high cost associated with surgeries, stern regulatory environment for product approval and growing popularity of minimally invasive surgeries are likely to restrict its growth in various regions.
The world biosurgery market was evaluated at $6,912.2 million in 2014, and is estimated to garner $12,758.1 million by 2022, registering a CAGR of 8.1% over the forecast period. The report segments the biosurgery market on the basis of product type, application, source, and geography. On the basis of product type, the market is segmented into anti-adhesive agents, hemostatic agents, surgical sealants, bone graft substitutes, and soft tissue management (mesh/patch). According to application, it is classified into cardiovascular and thoracic, neuro and spine, orthopedic, general, and others surgeries. Others surgery covers urological, gynecological, rhytidectomy, and reconstructive surgeries. Based on the source, it is segmented into natural and synthetic products. Geographic breakdown and a deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and LAMEA.
High investment from top players and increasing R&D spending on multi-usage products (such as fibrin sealants) are likely to provide ample opportunities to the industry players across regions. Recently in 2015, the U.S. FDA approved Infuse bone graft implantation from Medtronic PLC, which is made up of polyetheretherketone compound, for oblique lateral interbody fusion and anterior lumbar interbody fusion. Furthermore, in March 2015, Kuros Biosurgery received a U.S. patent for its synthetic hydrogel technology. It is a combination of bioactivebiomaterial products such as sealant and orthobiologics. A comprehensive competitive analysis and profiles of major industry players such as Johnson & Johnson (Ethicon), Baxter International, Medtronic PLC, Stryker, Atrium Medical (Maquet Getinge Group), C. R. Bard, CryoLife Inc., Haemostasis LLC, Kuros Bioscience, and Sanofi are also provided in this report.
KEY BENEFITS FOR STAKEHOLDERS:
- A comprehensive analysis of factors that drive and restrict the growth of the world Biosurgery market is provided in this report.
- The study provides an in-depth analysis of this market with current trends and forecasts to elucidate the imminent investment pockets.
- The report provides a quantitative analysis from 2014 to 2022, which is likely to enable the stakeholders to capitalize on prevailing growth opportunities.
- Extensive analysis of this market, by component, helps in understanding the products that are currently used along with the variants which are expected to gain prominence in future.
- Competitive intelligence among top players helps in understanding the competitive scenario across different geographic locations and the strategies adopted by them to increase their market share across various regions.
- SWOT analysis highlights the internal and external environment of leading companies for effective strategy formulation.
- By Product Type
- Anti-adhesive agents
- Hemostatic agents
- Surgical sealing agents
- Natural surgical sealant
- Synthetic surgical sealant
- Bone graft substitutes
- Cell-based matrices
- Bone morphogenetic proteins
- Demineralized bone matrix
- Synthetic graft extender
- Soft tissue management (mesh/patch)
- Biologic mesh/patch
- Allografts
- Xenografts
- Synthetic mesh/patch
- By Application
- Cardiovascular and thoracic surgery
- Neuro- and spine surgery
- Orthopedic surgery
- General surgery
- Others (Reconstructive, Urology, and Gynecology Surgeries)
- By Source
- Natural/Biologics products
- Synthetic products
- By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Others
- Asia-Pacific
- Australia
- Japan
- India
- China
- Others
- LAMEA
- Latin America
- Middle East
- Africa
CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.1.1 Base case scenario
2.1.2 Rapid growth scenario
2.1.3 Diminishing growth scenario
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.1.1 Top investment pockets
3.1.2 Top winning strategies
3.2 Porters five forces analysis
3.2.1 Bargaining power of suppliers
3.2.2 Bargaining power of buyers
3.2.3 Threats from new entrants
3.2.4 Competitive rivalry
3.2.5 Threats from substitute products
3.3 Market share analysis, 2014
3.4 Drivers
3.4.1 Rising prevalence of chronic diseases and related surgeries
3.4.2 Rising geriatric and obese population
3.4.3 Technological advancements
3.4.4 Aggressive market strategies adopted by top players
3.5 Restraints
3.5.1 High cost associated with surgeries
3.5.2 Strict regulation and reimbursement issues
3.5.3 Lack of awareness in LAMEA region
3.5.4 Increasing popularity of minimally invasive surgeries
3.6 Opportunities
3.6.1 Availability of multifunctional products
3.6.2 Rapidly changing healthcare infrastructure in developing countries
CHAPTER 4 WORLD BIOSURGERY MARKET, BY PRODUCT, 2014-2022
4.1 Overview
4.1.1 Market size and forecast
4.2 Anti-adhesive agents
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.3 Hemostatic agents
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.4 Surgical sealing agents
4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
4.4.4 Natural/biologics surgical sealant
4.4.4.1 Market size and forecast
4.4.5 Synthetic surgical sealants
4.4.5.1 Market size and forecast
4.5 Bone Graft Substitutes
4.5.1 Key market trends
4.5.2 Key growth factors and opportunities
4.5.3 Market size and forecast
4.5.4 Cell based matrices
4.5.4.1 MArket size and forecast
4.5.5 Bone morphogenetic proteins
4.5.5.1 MArket size and forecast
4.5.6 Demineralised bone matrix
4.5.6.1 MArket size and forecast
4.5.7 Synthetic grafts extenders
4.5.7.1 MArket size and forecast
4.6 Soft tissue management (mesh/patch)
4.6.1 Key market trends
4.6.2 Key growth factors and opportunities
4.6.3 Market size and forecast
4.6.4 Biologics/natural soft tissue management (mesh/patch)
4.6.4.1 MArket size and forecast
4.6.5 Synthetic soft tissue management (mesh/patch)
4.6.5.1 MArket size and forecast
CHAPTER 5 WORLD BIOSURGERY MARKET, BY APPLICATION, 2014-2022 OVERVIEW
5.1.1 Market size and forecast
5.2 Cardiovascular and thoracic surgery
5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.3 Neuro and Spine surgery
5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast
5.4 Orthopaedic surgery
5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.5 General surgery
5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast
5.6 Others
5.6.1 Key market trends
5.6.2 Key growth factors and opportunities
5.6.3 Market size and forecast
CHAPTER 6 WORLD BIOSURGERY MARKET, BY SOURCE, 2014-2022
6.1 Overview
6.1.1 Market size and forecast
6.2 Biologics Products
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.3 Synthetics products
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
CHAPTER 7 WORLD BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast
7.3 Europe
7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast
7.4 Asia Pacific
7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast
7.5 LAMEA
7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast
CHAPTER 8 COMPANY PROFILES
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Business performance
8.1.4 Key strategic moves and developments
8.1.5 SWOT analysis
8.2 Baxter International Inc.
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Business performance
8.2.4 Key strategic moves and developments
8.2.5 SWOT analysis
8.3 C. R. Bard Inc.
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Key strategic moves and developments
8.3.4 Business performance
8.3.5 SWOT analysis
8.4 Johnson and Johnson
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Business performance
8.4.4 Key strategic moves and developments
8.4.5 SWOT analysis
8.5 Stryker Corporation
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Business performance
8.5.4 Key strategic moves and developments
8.5.5 SWOT analysis
8.6 Sanofi S.A.
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Business performance
8.6.4 Key strategic moves and developments
8.6.5 SWOT analysis
8.7 Atrium Medical Corporation (Maquet Getinge Group)
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Business performance
8.7.4 SWOT analysis
8.8 Hemostasis LLC
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 SWOT analysis
8.9 Cryolife Inc.
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Business performance
8.9.4 Key strategic moves and developments
8.9.5 SWOT analysis
8.10 Kuros Bioscience
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Key strategic moves and developments
8.10.4 SWOT analysis
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.1.1 Base case scenario
2.1.2 Rapid growth scenario
2.1.3 Diminishing growth scenario
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.1.1 Top investment pockets
3.1.2 Top winning strategies
3.2 Porters five forces analysis
3.2.1 Bargaining power of suppliers
3.2.2 Bargaining power of buyers
3.2.3 Threats from new entrants
3.2.4 Competitive rivalry
3.2.5 Threats from substitute products
3.3 Market share analysis, 2014
3.4 Drivers
3.4.1 Rising prevalence of chronic diseases and related surgeries
3.4.2 Rising geriatric and obese population
3.4.3 Technological advancements
3.4.4 Aggressive market strategies adopted by top players
3.5 Restraints
3.5.1 High cost associated with surgeries
3.5.2 Strict regulation and reimbursement issues
3.5.3 Lack of awareness in LAMEA region
3.5.4 Increasing popularity of minimally invasive surgeries
3.6 Opportunities
3.6.1 Availability of multifunctional products
3.6.2 Rapidly changing healthcare infrastructure in developing countries
CHAPTER 4 WORLD BIOSURGERY MARKET, BY PRODUCT, 2014-2022
4.1 Overview
4.1.1 Market size and forecast
4.2 Anti-adhesive agents
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.3 Hemostatic agents
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.4 Surgical sealing agents
4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
4.4.4 Natural/biologics surgical sealant
4.4.4.1 Market size and forecast
4.4.5 Synthetic surgical sealants
4.4.5.1 Market size and forecast
4.5 Bone Graft Substitutes
4.5.1 Key market trends
4.5.2 Key growth factors and opportunities
4.5.3 Market size and forecast
4.5.4 Cell based matrices
4.5.4.1 MArket size and forecast
4.5.5 Bone morphogenetic proteins
4.5.5.1 MArket size and forecast
4.5.6 Demineralised bone matrix
4.5.6.1 MArket size and forecast
4.5.7 Synthetic grafts extenders
4.5.7.1 MArket size and forecast
4.6 Soft tissue management (mesh/patch)
4.6.1 Key market trends
4.6.2 Key growth factors and opportunities
4.6.3 Market size and forecast
4.6.4 Biologics/natural soft tissue management (mesh/patch)
4.6.4.1 MArket size and forecast
4.6.5 Synthetic soft tissue management (mesh/patch)
4.6.5.1 MArket size and forecast
CHAPTER 5 WORLD BIOSURGERY MARKET, BY APPLICATION, 2014-2022 OVERVIEW
5.1.1 Market size and forecast
5.2 Cardiovascular and thoracic surgery
5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.3 Neuro and Spine surgery
5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast
5.4 Orthopaedic surgery
5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.5 General surgery
5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast
5.6 Others
5.6.1 Key market trends
5.6.2 Key growth factors and opportunities
5.6.3 Market size and forecast
CHAPTER 6 WORLD BIOSURGERY MARKET, BY SOURCE, 2014-2022
6.1 Overview
6.1.1 Market size and forecast
6.2 Biologics Products
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.3 Synthetics products
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
CHAPTER 7 WORLD BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast
7.3 Europe
7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast
7.4 Asia Pacific
7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast
7.5 LAMEA
7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast
CHAPTER 8 COMPANY PROFILES
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Business performance
8.1.4 Key strategic moves and developments
8.1.5 SWOT analysis
8.2 Baxter International Inc.
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Business performance
8.2.4 Key strategic moves and developments
8.2.5 SWOT analysis
8.3 C. R. Bard Inc.
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Key strategic moves and developments
8.3.4 Business performance
8.3.5 SWOT analysis
8.4 Johnson and Johnson
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Business performance
8.4.4 Key strategic moves and developments
8.4.5 SWOT analysis
8.5 Stryker Corporation
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Business performance
8.5.4 Key strategic moves and developments
8.5.5 SWOT analysis
8.6 Sanofi S.A.
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Business performance
8.6.4 Key strategic moves and developments
8.6.5 SWOT analysis
8.7 Atrium Medical Corporation (Maquet Getinge Group)
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Business performance
8.7.4 SWOT analysis
8.8 Hemostasis LLC
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 SWOT analysis
8.9 Cryolife Inc.
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Business performance
8.9.4 Key strategic moves and developments
8.9.5 SWOT analysis
8.10 Kuros Bioscience
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Key strategic moves and developments
8.10.4 SWOT analysis
LIST OF TABLES
TABLE 1 WORLD BIOSURGERY BASE CASE SCENARIO MARKET, BY GEOGRAPHY, 2022-2027 ($MILLION)
TABLE 2 WORLD BIOSURGERY RAPID GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022-2027 ($MILLION)
TABLE 3 WORLD BIOSURGERY DIMINISHING GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022-2027 ($MILLION)
TABLE 4 WORLD BIOSURGERY MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 5 WORLD ANTI-ADHESIVE AGENTS BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 6 WORLD ANTI-ADHESIVE AGENTS BIOSURGERY MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 7 WORLD HEMOSTATIC AGENTS BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 8 WORLD HEMOSTATIC AGENTS BIOSURGERY MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 9 WORLD SURGICAL SEALANT MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 10 WORLD SURGICAL SEALANT MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 11 WORLD SURGICAL SEALANT MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 12 WORLD NATURAL SURGICAL SEALANT MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 13 WORLD SYNTHETIC SURGICAL SEALANT MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 14 WORLD BONE GRAFT SUBSTITUTE MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 15 WORLD BONE GRAFT SUBSTITUTE MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 16 WORLD BONE GRAFT SUBSTITUTE MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 17 WORLD CELL BASED MATRICES BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 18 WORLD BONE MORPHOGENETIC PROTEINS BISOURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 19 WORLD DEMINERALISED BONE MATRIX BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 20 WORLD SYNTHETIC GRAFT EXTENDERS BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 21 WORLD SOFT TISSUE MANAGEMENT (MESH/PATCH) BIOSURGERY MARKET, BY SOURCE, 2014-2022 ($MILLION)
TABLE 22 WORLD SOFT TISSUE MANAGEMENT (MESH/PATCH) BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 23 WORLD SOFT TISSUE MANAGEMENT (MESH/PATCH) BIOSURGERY MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 24 WORLD BIOLOGICS SOFT TISSUE MANAGEMENT BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 25 WORLD SYNTHETIC SOFT TISSUE MANAGEMENT BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 26 WORLD BIOSURGERY MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 27 WORLD CARDIOVASCULAR AND THORACIC BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 28 WORLD NEURO AND SPINE BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 29 WORLD ORTHOPEDIC BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 30 WORLD GENERAL BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 31 WORLD OTHERS BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 32 WORLD BIOSURGERY MARKET, BY SOURCES, 2014-2022 ($MILLION)
TABLE 33 WORLD BIOLOGIC BIOSURGERY PRODUCT MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 34 WORLD SYNTHETIC BIOSURGERY PRODUCT MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 35 WORLD BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 36 NORTH AMERICA BIOSURGERY MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 37 NORTH AMERICA BIOSURGERY MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 38 EUROPE BIOSURGERY MARKET, BY PRODUYCT TYPE, 2014-2022 ($MILLION)
TABLE 39 EUROPE BIOSURGERY MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 40 ASIA PACIFIC BIOSURGERY MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 41 ASIA PACIFIC BIOSURGERY MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 42 LAMEA BIOSURGERY MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 43 LAMEA BIOSURGERY MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 44 COMPANY SNAPSHOT OF A MEDTRONIC PLC
TABLE 45 COMPANY SNAPSHOT OF ST. JUDE MEDICAL INC.
TABLE 46 COMPANY SNAPSHOT OF C. R. BARD INC.
TABLE 47 COMPANY SNAPSHOT OF JOHNSON AND JOHNSON
TABLE 48 COMPANY SNAPSHOT OF STRYKER CORPORATION
TABLE 49 COMPANY SNAPSHOT OF SANOFI S.A.
TABLE 50 COMPANY SNAPSHOT OF CISCO SYSTMES INC.
TABLE 51 COMPANY SNAPSHOT OF HEMOSTATIS LLC.
TABLE 52 COMPANY SNAPSHOT OF CRYOLIFE INC.
TABLE 53 COMPANY SNAPSHOT OF KUROS BIOSCIENCE
TABLE 1 WORLD BIOSURGERY BASE CASE SCENARIO MARKET, BY GEOGRAPHY, 2022-2027 ($MILLION)
TABLE 2 WORLD BIOSURGERY RAPID GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022-2027 ($MILLION)
TABLE 3 WORLD BIOSURGERY DIMINISHING GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022-2027 ($MILLION)
TABLE 4 WORLD BIOSURGERY MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 5 WORLD ANTI-ADHESIVE AGENTS BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 6 WORLD ANTI-ADHESIVE AGENTS BIOSURGERY MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 7 WORLD HEMOSTATIC AGENTS BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 8 WORLD HEMOSTATIC AGENTS BIOSURGERY MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 9 WORLD SURGICAL SEALANT MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 10 WORLD SURGICAL SEALANT MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 11 WORLD SURGICAL SEALANT MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 12 WORLD NATURAL SURGICAL SEALANT MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 13 WORLD SYNTHETIC SURGICAL SEALANT MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 14 WORLD BONE GRAFT SUBSTITUTE MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 15 WORLD BONE GRAFT SUBSTITUTE MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 16 WORLD BONE GRAFT SUBSTITUTE MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 17 WORLD CELL BASED MATRICES BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 18 WORLD BONE MORPHOGENETIC PROTEINS BISOURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 19 WORLD DEMINERALISED BONE MATRIX BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 20 WORLD SYNTHETIC GRAFT EXTENDERS BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 21 WORLD SOFT TISSUE MANAGEMENT (MESH/PATCH) BIOSURGERY MARKET, BY SOURCE, 2014-2022 ($MILLION)
TABLE 22 WORLD SOFT TISSUE MANAGEMENT (MESH/PATCH) BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 23 WORLD SOFT TISSUE MANAGEMENT (MESH/PATCH) BIOSURGERY MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 24 WORLD BIOLOGICS SOFT TISSUE MANAGEMENT BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 25 WORLD SYNTHETIC SOFT TISSUE MANAGEMENT BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 26 WORLD BIOSURGERY MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 27 WORLD CARDIOVASCULAR AND THORACIC BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 28 WORLD NEURO AND SPINE BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 29 WORLD ORTHOPEDIC BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 30 WORLD GENERAL BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 31 WORLD OTHERS BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 32 WORLD BIOSURGERY MARKET, BY SOURCES, 2014-2022 ($MILLION)
TABLE 33 WORLD BIOLOGIC BIOSURGERY PRODUCT MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 34 WORLD SYNTHETIC BIOSURGERY PRODUCT MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 35 WORLD BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 36 NORTH AMERICA BIOSURGERY MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 37 NORTH AMERICA BIOSURGERY MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 38 EUROPE BIOSURGERY MARKET, BY PRODUYCT TYPE, 2014-2022 ($MILLION)
TABLE 39 EUROPE BIOSURGERY MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 40 ASIA PACIFIC BIOSURGERY MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 41 ASIA PACIFIC BIOSURGERY MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 42 LAMEA BIOSURGERY MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 43 LAMEA BIOSURGERY MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 44 COMPANY SNAPSHOT OF A MEDTRONIC PLC
TABLE 45 COMPANY SNAPSHOT OF ST. JUDE MEDICAL INC.
TABLE 46 COMPANY SNAPSHOT OF C. R. BARD INC.
TABLE 47 COMPANY SNAPSHOT OF JOHNSON AND JOHNSON
TABLE 48 COMPANY SNAPSHOT OF STRYKER CORPORATION
TABLE 49 COMPANY SNAPSHOT OF SANOFI S.A.
TABLE 50 COMPANY SNAPSHOT OF CISCO SYSTMES INC.
TABLE 51 COMPANY SNAPSHOT OF HEMOSTATIS LLC.
TABLE 52 COMPANY SNAPSHOT OF CRYOLIFE INC.
TABLE 53 COMPANY SNAPSHOT OF KUROS BIOSCIENCE
LIST OF FIGURES
FIG. 1 TOP IMPACTING FACTORS, BASE CASE SCENARIO (2022-2027)
FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2022-2027)
FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2022-2027)
FIG. 4 KEY FINDINGS
FIG. 1 TOP INVESTMENT POCKETS IN WORLD BIOSURGERY MARKET
FIG. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION
FIG. 3 TOP WINNING STRATEGIES: NATURE AND TYPE
FIG. 4 PORTERS FIVE FORCES ANALYSIS
FIG. 5 TOP IMPACTING FACTORS
FIG. 6 MARKET SHARE ANALYSIS, 2014
FIG. 7 A MEDTRONIC PLC, REVENUE, 2012-2014 ($MILLION)
FIG. 8 A MEDTRONIC PLC, % REVENUE, BY BUSINESS SEGMENT (2014)
FIG. 9 A MEDTRONIC PLC, % REVENUE, BY GEOGRAPHY (2014)
FIG. 10 SWOT ANALYSIS OF MEDTRONIC PLC
FIG. 11 BAXTER INTERNATIONAL INC., REVENUE, 2012-2014 ($MILLION)
FIG. 12 BAXTER INTERNATIONAL INC., % REVENUE, BY BUSINESS SEGMENT (2014)
FIG. 13 BAXTER INTERNATIONAL INC., % REVENUE, BY GEOGRAPHY (2014)
FIG. 14 SWOT ANALYSIS OF BAXTER INTERNATIONAL INC.
FIG. 15 C. R. BARD INC., REVENUE, 2012-2014 ($MILLION)
FIG. 16 C. R. BARD INC., % REVENUE, BY BUSINESS SEGMENT (2014)
FIG. 17 SWOT ANALYSIS OF C. R. BARD INC.
FIG. 18 JOHNSON AND JOHNSON, REVENUE, 2012-2014 ($MILLION)
FIG. 19 JOHNSON AND JOHNSON, % REVENUE, BY BUSINESS SEGMENT (2014)
FIG. 20 JOHNSON AND JOHNSON, % REVENUE, BY GEOGRAPHY (2014)
FIG. 21 SWOT ANALYSIS OF JOHNSON AND JOHNSON
FIG. 22 STRYKER CORPORATION, REVENUE, 2012-2014 ($MILLION)
FIG. 23 STRYKER CORPORATION, % REVENUE, BY BUSINESS SEGMENT (2014)
FIG. 24 SWOT ANALYSIS OF STRYKER CORPORATION
FIG. 25 SANOFI S.A., REVENUE, 2012-2014 ($MILLION)
FIG. 26 SAOFI S.A., % REVENUE, BY BUSINESS SEGMENT (2014)
FIG. 27 SANOFI S.A., % REVENUE, BY GEOGRAPHY (2014)
FIG. 28 SWOT ANALYSIS OF SANOFI S.A.
FIG. 29 ATRIUM MEDICAL CORPORATION (MAQUET GETINGE GROUP), REVENUE, 2012-2014 ($MILLION)
FIG. 30 ATRIUM MEDICAL CORPORATION (MAQUET GETINGE GROUP), % REVENUE, BY BUSINESS SEGMENT (2014)
FIG. 31 ATRIUM MEDICAL CORPORATION (MAQUET GETINGE GROUP) MEDICAL SYSTEM, % REVENUE, BY GEOGRAPHY (2014)
FIG. 32 SWOT ANALYSIS OF ATRIUM MEDICAL CORPORATION (MAQUET GETINGE GROUP)
FIG. 33 SWOT ANALYSIS OF HEMOSTATIS LLC
FIG. 34 CRYOLIFE INC., REVENUE, 2012-2014 ($MILLION)
FIG. 35 CRYOLIFE INC., % REVENUE, BY REVENUE SOURCE (2014)
FIG. 36 CRYOLIFE INC.S MEDICAL DEVICES SEGMENT, % REVENUE, BY REVENUE SOURCE (2014)
FIG. 37 SWOT ANALYSIS OF CRYOLIFE INC.
FIG. 38 SWOT ANALYSIS OF KUROS BIOSCIENCE
FIG. 1 TOP IMPACTING FACTORS, BASE CASE SCENARIO (2022-2027)
FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2022-2027)
FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2022-2027)
FIG. 4 KEY FINDINGS
FIG. 1 TOP INVESTMENT POCKETS IN WORLD BIOSURGERY MARKET
FIG. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION
FIG. 3 TOP WINNING STRATEGIES: NATURE AND TYPE
FIG. 4 PORTERS FIVE FORCES ANALYSIS
FIG. 5 TOP IMPACTING FACTORS
FIG. 6 MARKET SHARE ANALYSIS, 2014
FIG. 7 A MEDTRONIC PLC, REVENUE, 2012-2014 ($MILLION)
FIG. 8 A MEDTRONIC PLC, % REVENUE, BY BUSINESS SEGMENT (2014)
FIG. 9 A MEDTRONIC PLC, % REVENUE, BY GEOGRAPHY (2014)
FIG. 10 SWOT ANALYSIS OF MEDTRONIC PLC
FIG. 11 BAXTER INTERNATIONAL INC., REVENUE, 2012-2014 ($MILLION)
FIG. 12 BAXTER INTERNATIONAL INC., % REVENUE, BY BUSINESS SEGMENT (2014)
FIG. 13 BAXTER INTERNATIONAL INC., % REVENUE, BY GEOGRAPHY (2014)
FIG. 14 SWOT ANALYSIS OF BAXTER INTERNATIONAL INC.
FIG. 15 C. R. BARD INC., REVENUE, 2012-2014 ($MILLION)
FIG. 16 C. R. BARD INC., % REVENUE, BY BUSINESS SEGMENT (2014)
FIG. 17 SWOT ANALYSIS OF C. R. BARD INC.
FIG. 18 JOHNSON AND JOHNSON, REVENUE, 2012-2014 ($MILLION)
FIG. 19 JOHNSON AND JOHNSON, % REVENUE, BY BUSINESS SEGMENT (2014)
FIG. 20 JOHNSON AND JOHNSON, % REVENUE, BY GEOGRAPHY (2014)
FIG. 21 SWOT ANALYSIS OF JOHNSON AND JOHNSON
FIG. 22 STRYKER CORPORATION, REVENUE, 2012-2014 ($MILLION)
FIG. 23 STRYKER CORPORATION, % REVENUE, BY BUSINESS SEGMENT (2014)
FIG. 24 SWOT ANALYSIS OF STRYKER CORPORATION
FIG. 25 SANOFI S.A., REVENUE, 2012-2014 ($MILLION)
FIG. 26 SAOFI S.A., % REVENUE, BY BUSINESS SEGMENT (2014)
FIG. 27 SANOFI S.A., % REVENUE, BY GEOGRAPHY (2014)
FIG. 28 SWOT ANALYSIS OF SANOFI S.A.
FIG. 29 ATRIUM MEDICAL CORPORATION (MAQUET GETINGE GROUP), REVENUE, 2012-2014 ($MILLION)
FIG. 30 ATRIUM MEDICAL CORPORATION (MAQUET GETINGE GROUP), % REVENUE, BY BUSINESS SEGMENT (2014)
FIG. 31 ATRIUM MEDICAL CORPORATION (MAQUET GETINGE GROUP) MEDICAL SYSTEM, % REVENUE, BY GEOGRAPHY (2014)
FIG. 32 SWOT ANALYSIS OF ATRIUM MEDICAL CORPORATION (MAQUET GETINGE GROUP)
FIG. 33 SWOT ANALYSIS OF HEMOSTATIS LLC
FIG. 34 CRYOLIFE INC., REVENUE, 2012-2014 ($MILLION)
FIG. 35 CRYOLIFE INC., % REVENUE, BY REVENUE SOURCE (2014)
FIG. 36 CRYOLIFE INC.S MEDICAL DEVICES SEGMENT, % REVENUE, BY REVENUE SOURCE (2014)
FIG. 37 SWOT ANALYSIS OF CRYOLIFE INC.
FIG. 38 SWOT ANALYSIS OF KUROS BIOSCIENCE
